Clinical Trials
128 trialsA Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
UNC Lineberger Comprehensive Cancer Center
retroESGO ov1
European Society of Gynaecological Oncology
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
TROY
Yonsei University
EPOCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Brown University
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Dana-Farber Cancer Institute
A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CALM-TF
University Health Network, Toronto
A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer
Zhongnan Hospital
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Virginia Commonwealth University
CYCLOPS
CNAO National Center of Oncological Hadrontherapy
RACC
Karolinska Institutet
NIRAPK
Hospices Civils de Lyon
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Esperas Pharma Inc.
QLPPEC/GOG-003
Tianjin Medical University Cancer Institute and Hospital
COMPASS
North Eastern German Society of Gynaecological Oncology
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Newton
Mario Negri Institute for Pharmacological Research
QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer
Peking Union Medical College Hospital
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
Women's Hospital School Of Medicine Zhejiang University
TEDOVA
ARCAGY/ GINECO GROUP
"Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University Health Network, Toronto
Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery
Cukurova University
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Chinese PLA General Hospital
POPOPO
Seoul National University Hospital
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
M.D. Anderson Cancer Center
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia
Imperial College London
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
Loyola University
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer
Memorial Sloan Kettering Cancer Center
HETERERO
Charite University, Berlin, Germany
A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer
Tongji Hospital
Retro-COSMOS
Erasmus Medical Center
ENDOVIE
ARCAGY/ GINECO GROUP
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Cantonal Hospital of St. Gallen
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
GI-HPVT-01
BGI, China
DaRT-V
Cambridge University Hospitals NHS Foundation Trust
The Role of Pre-operative and Post-operative Circulating Tumor Cells in Gastric Cancer.
Chang Gung Memorial Hospital
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer
H. Lee Moffitt Cancer Center and Research Institute
BOLD
ARCAGY/ GINECO GROUP
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
Ruhr University of Bochum
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Ruhr University of Bochum
Prognosis of Low-grade Endometrial Stromal Sarcoma
Peking Union Medical College Hospital
Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
Southern Illinois University
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
British Columbia Cancer Agency
DESKTOPIII
AGO Study Group